Article
Metal- and metalloid-based compounds to target and reverse cancer multidrug resistance
6 Aug 2021
Abstract excerpt
Drug resistance remains the major cause of cancer treatment failure especially at the late stage of the disease. However, based on their versatile chemistry, metal and metalloid compounds offer the possibility to design fine-tuned drugs to circumvent and even specifically target drug-resistant cancer cells. Based on the paramount importance of platinum drugs in the clinics, two main areas of drug resistance...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
